(Q33708071)

English

Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

anti-retroviral agent

0 references

8

object named as

Ian Sanne

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

6

object named as

Susan H Eshleman

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

7

object named as

Judith Aberg

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

10

object named as

Angela Kashuba

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

author name string

Charles Flexner

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Camlin Tierney

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Robert Gross

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Adriana Andrade

4

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Christina Lalama

5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Teresa Parsons

9

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Susan L Rosenkranz

11

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Anne Kmack

12

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Elaine Ferguson

13

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Marjorie Dehlinger

14

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Donna Mildvan

15

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

ACTG A5073 Study Team

16

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

language of work or name

0 references

publication date

1 April 2010

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

50

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1041-1052

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833234

21 June 2018

HIV drug development: the next 25 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833234

21 June 2018

Estimation of the comparative therapeutic superiority of QD and BID dosing regimens, based on integrated analysis of dosing history data and pharmacokinetics.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833234

21 June 2018

Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833234

21 June 2018

Factors associated with nonadherence to highly active antiretroviral therapy: a 5-year follow-up analysis with correction for the bias induced by missing data in the treatment maintenance phase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833234

21 June 2018

Patient adherence to prescribed antimicrobial drug dosing regimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833234

21 June 2018

Overcoming obstacles to the success of protease inhibitors in highly active antiretroviral therapy regimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833234

21 June 2018

A systematic review of the associations between dose regimens and medication compliance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833234

21 June 2018

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833234

21 June 2018

How often is medication taken as prescribed? A novel assessment technique

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833234

21 June 2018

A once-daily lopinavir/ritonavir-based regimen is noninferior to twice-daily dosing and results in similar safety and tolerability in antiretroviral-naive subjects through 48 weeks

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833234

30 October 2018

Switching from twice-daily abacavir and lamivudine to the once-daily fixed-dose combination tablet of abacavir and lamivudine improves patient adherence and satisfaction with therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833234

30 October 2018

The tablet formulation of lopinavir/ritonavir provides similar bioavailability to the soft-gelatin capsule formulation with less pharmacokinetic variability and diminished food effect.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833234

30 October 2018

High-performance liquid chromatography assay for the quantification of HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in human plasma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833234

30 October 2018

Once-daily versus twice-daily lopinavir/ritonavir in antiretroviral-naive HIV-positive patients: a 48-week randomized clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833234

30 October 2018

Effect of adherence to newly initiated antiretroviral therapy on plasma viral load

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833234

30 October 2018

Less is More: Medicines that Require Less Frequent Administration Improve Adherence, but Are They Better?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833234

30 October 2018

A once-daily lopinavir/ritonavir-based regimen provides noninferior antiviral activity compared with a twice-daily regimen

1 reference

https://pubmed.ncbi.nlm.nih.gov/20192725

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: Evidence from a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20192725

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20192725

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33708071&oldid=2143560815"